Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
https://doi.org/10.20996/1819-6446-2015-11-6-634-637
Abstract
A hypothesis that possible pleiotropic features of different statins could be explained by distinctions in their interaction with cell membrane is suggested. Molecular complexes of pravastatin and simvastatin with model of cell membrane were studied by method of nuclear magnetic resonance spectroscopy. It was shown that pravastatin interacts almost exclusively with a surface of cell membrane and, therefore active transport system is needed to deliver pravastatin into the cell. In contrast, simvastatin is located in the inner part of model cell membrane. That’s why it can passively penetrate into organism cells. Perhaps, these differences lead to distinctions of pleiotropic properties of these statins.
About the Authors
I. A. Latfullin
Kazan Federal University, Institute of Physics. Kremlevskaya ul. 18, Kazan, 420008, Russia
Russian Federation
Russian Federation
L. F. Galiullina
Kazan Federal University, Institute of Physics. Kremlevskaya ul. 18, Kazan, 420008, Russia
Russian Federation
Russian Federation
I. Z. Rakhmatullin
Kazan Federal University, Institute of Physics. Kremlevskaya ul. 18, Kazan, 420008, Russia
Russian Federation
Russian Federation
V. V. Klochkov
Kazan Federal University, Institute of Physics. Kremlevskaya ul. 18, Kazan, 420008, Russia
Russian Federation
Russian Federation
A. V. Aganov
Kazan Federal University, Institute of Physics. Kremlevskaya ul. 18, Kazan, 420008, Russia
Russian Federation
Russian Federation
References
1. Scandinavian Simvastatin Survival Study Group. Randomised trial of Cholesterol lowering in 4444 patients coronary heart disease in Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
2. Aronov DM. Pleiotropic effects of statins. Kardiologiia 2008; 8: 60-8. In Russian (Аронов Д.М. Плейотропные эффекты статинов. Кардиология 2008; 8: 60-8).
3. Pokrovskaya EV, Gratsianskii NA, Averkov OV, et al. Acute coronary syndrome without ST-segment elevation on ECG: opposite changes of hemostasis with early use of atorvastatin and pravastatin. Kardiologiia 2003; 6: 4-13. In Russian (Покровская Е.В., Грацианский Н.А., Аверков О.В., и др. Острый коронарный синдром без подъемов сегмента ST на ЭКГ: разнонаправленные изменения показателей гемостаза при раннем применении аторвастатина и правастатина. Кардиология 2003; 6: 4-13).
4. Thomson GR A handbook of hyperlipidemia. London: Current Science; 1989.
5. Mason R.P., Walter M.F., Day Ch.A., Jacob R.F. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. The American journal of cardiology 2005; 96: 11F-23F.
6. Callion L., Lequin O., Khemtemourian L. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation. Biochim. Biophys. Acta 2013; 1828: 2091-8.
7. Henry G.D., Sykes B.D. Methods to study membrane protein structure in solution. Methods Enzymol 1994; 239: 515-35.
8. Galiullina L.F., Blokhin D.S., Aganov A.V., Klochkov V.V. Investigation of cholesterol+model of biological membrane complex by NMR spectroscopy. MRSej 2012; 14: 12204-10.
9. Novotna P., Goncharova I., Urbanova M. Mutual structural effect of bilirubin and model membranes by vibrational circular dichroism. Biochim. Biophys. Acta 2014; 1838: 831-41.
10. Usachev K.S., Filippov A.V., Filippova E.A., et al. Solution structures of Altzheimers amyloid Aβ13-23
11. peptide: NMR studies in solution and in SDS. J Mol Struct 2013; 1049: 436-40.
12. Galiullina L.F., Rakhmatullin I.Z., Klochkova E.A., et al. Structure of pravastatin and its complex with sodium dodecyl sulfate micelles studied by NMR spectroscopy. Magnetic resonance in chemistry 2015; 53(2): 110-4.
13. Wang G., Keifer P., Peterkofsky A. Solution structure of the N-terminal amphitropic domain of Escherichia coli glucose-specific enzyme IIA in membrane-mimetic micelles. Protein Science 2003; 12: 1087-96.
Review
For citations:
Latfullin I.A., Galiullina L.F., Rakhmatullin I.Z., Klochkov V.V., Aganov A.V. Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? Rational Pharmacotherapy in Cardiology. 2015;11(6):634-637. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-6-634-637
Views:
1079
Email this article 